Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy. Here's what we know so far about this promising new option for those ...

“We should be moving away from a simplistic percent weight loss as the sole obesity treatment target in research, despite its ease of use and measurement, and move towards more comprehensive ...